RLAY
Price
$8.86
Change
-$0.06 (-0.67%)
Updated
Feb 9, 11:22 AM (EDT)
Capitalization
1.55B
10 days until earnings call
Intraday BUY SELL Signals
TECX
Price
$24.68
Change
+$0.31 (+1.27%)
Updated
Feb 9, 12:44 PM (EDT)
Capitalization
456.12M
Intraday BUY SELL Signals
Interact to see
Advertisement

RLAY vs TECX

Header iconRLAY vs TECX Comparison
Open Charts RLAY vs TECXBanner chart's image
Relay Therapeutics
Price$8.86
Change-$0.06 (-0.67%)
Volume$709
Capitalization1.55B
Tectonic Therapeutic
Price$24.68
Change+$0.31 (+1.27%)
Volume$1.51K
Capitalization456.12M
RLAY vs TECX Comparison Chart in %
RLAY
Daily Signal:
Gain/Loss:
TECX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
RLAY vs. TECX commentary
Feb 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLAY is a StrongBuy and TECX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 09, 2026
Stock price -- (RLAY: $8.92 vs. TECX: $24.37)
Brand notoriety: RLAY and TECX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLAY: 147% vs. TECX: 99%
Market capitalization -- RLAY: $1.55B vs. TECX: $456.12M
RLAY [@Biotechnology] is valued at $1.55B. TECX’s [@Biotechnology] market capitalization is $456.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.26B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLAY’s FA Score shows that 1 FA rating(s) are green whileTECX’s FA Score has 0 green FA rating(s).

  • RLAY’s FA Score: 1 green, 4 red.
  • TECX’s FA Score: 0 green, 5 red.
According to our system of comparison, RLAY is a better buy in the long-term than TECX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLAY’s TA Score shows that 5 TA indicator(s) are bullish while TECX’s TA Score has 6 bullish TA indicator(s).

  • RLAY’s TA Score: 5 bullish, 4 bearish.
  • TECX’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, both RLAY and TECX are a good buy in the short-term.

Price Growth

RLAY (@Biotechnology) experienced а +16.45% price change this week, while TECX (@Biotechnology) price change was +21.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.93%. For the same industry, the average monthly price growth was -2.54%, and the average quarterly price growth was +26.81%.

Reported Earning Dates

RLAY is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (-0.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($1.55B) has a higher market cap than TECX($456M). TECX YTD gains are higher at: 16.826 vs. RLAY (5.437). TECX has higher annual earnings (EBITDA): -64.7M vs. RLAY (-322.8M). RLAY has more cash in the bank: 596M vs. TECX (268M). TECX has less debt than RLAY: TECX (1.24M) vs RLAY (33.3M). RLAY has higher revenues than TECX: RLAY (8.36M) vs TECX (0).
RLAYTECXRLAY / TECX
Capitalization1.55B456M339%
EBITDA-322.8M-64.7M499%
Gain YTD5.43716.82632%
P/E RatioN/A4.59-
Revenue8.36M0-
Total Cash596M268M222%
Total Debt33.3M1.24M2,690%
FUNDAMENTALS RATINGS
TECX: Fundamental Ratings
TECX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
71
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RLAYTECX
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Momentum
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 25 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
RLAY
Daily Signal:
Gain/Loss:
TECX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TOVIX22.730.53
+2.39%
American Beacon IMC Int Small Cap R5
SILLX29.620.60
+2.07%
Franklin Global Equity C
EMQIX10.650.21
+2.01%
Ashmore Emerging Markets Active Eq Instl
DWOAX18.980.36
+1.93%
BNY Mellon Research Growth A
TAGRX64.020.46
+0.72%
JHancock Fundamental Large Cap Core A

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with NRIX. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
+9.45%
NRIX - RLAY
61%
Loosely correlated
+5.64%
IMNM - RLAY
59%
Loosely correlated
+3.67%
RCUS - RLAY
55%
Loosely correlated
+4.99%
BDTX - RLAY
55%
Loosely correlated
+4.40%
DNLI - RLAY
54%
Loosely correlated
+5.29%
More

TECX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECX has been loosely correlated with IGC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TECX jumps, then IGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECX
1D Price
Change %
TECX100%
+6.61%
IGC - TECX
49%
Loosely correlated
+0.81%
NUVL - TECX
42%
Loosely correlated
+2.67%
NRIX - TECX
41%
Loosely correlated
+5.64%
SANA - TECX
40%
Loosely correlated
+10.70%
RLAY - TECX
40%
Loosely correlated
+9.45%
More